Bank Bumi Arta Tbk vs Merck Tbk. — how do they compare? Bank Bumi Arta Tbk trades at Rp750 (market cap 2.5T, 800 24h volume), while Merck Tbk. trades at Rp3,830 (market cap 1.7T, 13.7K 24h volume). The key difference: Bank Bumi Arta Tbk is the larger of the two by market cap, and Merck Tbk. is more actively traded (13.7K versus 800). Which is the better fit depends on your goals.
| BNBA | MERK | |
|---|---|---|
Market Cap | 2.5T | 1.7T |
Volume | 800 | 13.7K |
Lot | 8 | 137 |
Turnover | 598.5K | 52.45M |
Average Price | 748.13 | 3,828.69 |
Value | 598.5K | 52.45M |
Indicative Equilibrium Price | — | 3,850 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bank Bumi Arta (the company) was established under its original name of PT Bank Bumi Arta Indonesia on Mar 3, 1967 then changed to PT Bank Bumi Arta based on Notaries Deed dated Jul 19, 1989 and the deed of establishment was approved by the the Ministry of Justice dated Sept 14, 1992. The Company was merged with PT Bank Duta Nusantara (d/h PT Bank Pegawai) to improve operational banking network and to increase capital structure.The Company’s articles of association has been amended several times, most recently by notarial deed No. 8 of Fathiah Helmi, S.H., dated Mar 9, 2006, concerning company public offering.
Read more on BNBA →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →